New semi-quantitative 123I-MIBG estimation method compared with scoring system in follow-up of advanced neuroblastoma: Utility of total MIBG retention ratio versus scoring method

Annals of Nuclear Medicine

Volumn 26, Issue 6, 2012, Pages 462-470

  Sano, Yuko ^a   Okuyama, Chio ^a   Iehara, Tomoko ^a   Matsushima, Shigenori ^a   Yamada, Kei ^a   Hosoi, Hajime ^a   Nishimura, Tsunehiko ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

123I MIBG scintigraphy; Advanced neuroblastoma; Scoring system; Urinary homovanillic acid; Urinary vanillylmandelic acid

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; CATECHOLAMINE; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; HOMOVANILLIC ACID; PIRARUBICIN; TUMOR MARKER; VANILMANDELIC ACID; VINCRISTINE;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CATECHOLAMINE URINE LEVEL; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; DRUG RETENTION; FEMALE; FOLLOW UP; HUMAN; IMAGING AND DISPLAY; INTERNATIONAL NEUROBLASTOMA RISK GROUP STAGING SYSTEM; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCINTIGRAPHY; SCORING SYSTEM; TREATMENT RESPONSE; TUMOR LOCALIZATION;

3-IODOBENZYLGUANIDINE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; NEOPLASM STAGING; NEUROBLASTOMA; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84864713302     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-012-0596-1     Document Type: Article

References (19)

1. Fukushima T, Shichino H, Kumagai M. Neuroblastoma trial to overcome a rare malignant disease. Jpn J Cancer chemother. 2007;34:167-74.
2. Hickeson MP, Charron M, Maris JM, John M, Brophy P, Kang TI, Zhaung H, et al. Biodistribution of post-therapeutic versus diagnostic 131I-MIBG scans in children with neuroblastoma. Pediatr Blood Cancer. 2004;42:268-74. (Pubitemid 38235078)
3. Shulkin BL, Shapiro B. Current concepts on the diagnostic use of MIBG in children. J Nucl Med. 1998;39:679-88. (Pubitemid 28175849)
4. Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol. 2009;27:298-303.
5. Maurea S, Lastoria S, Caraco C, Indolfi P, Casale F, Tullio MT, et al. Iodine-131-MIBG imaging to monitor chemotherapy response in advanced neuroblastoma: comparison with laboratory analysis. J Nucl Med. 1994;35:1429-35. (Pubitemid 24280447)
6. 123I- metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) task force. Br J Cancer. 2010;102:1319-26.
7. 123I-MIBG whole body scan scoring method - application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastoma. Eur J Cancer. 1995;31A:256-61.
8. Perel Y, Conway J, Kletzel M, Goldman J, Weiss S, Fleyler A, et al. Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma. J Pediatr Hematol Oncol. 1999;21:13-8. (Pubitemid 29131988)
9. Katzenstein HM, Cohn SL, Shore RM, Bardo DME, Haut PR, Olszewski M, et al. Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in highrisk neuroblastoma. J Clin Oncol. 2004;22:3909-15. (Pubitemid 41079872)
10. Messina JA, Cheng SC, Franc BL, Charron M, Shulkin B, To Bao, et al. Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma. Pediatr Blood Cancer. 2006;47:865-74. (Pubitemid 44656106)
11. Boubaker A, Delaloye AB. MIBG scintigraphy for the diagnosis and follow-up of children with neuroblastoma. Q J Nucl Med Mol Imaging. 2008;52:388-402.
12. 123I-mIBG in patients with stage 4 neuroblastoma>1 year of age on a high-risk treatment protocol: results of the German Neuroblastoma Trial NB97. Eur J Cancer. 2008;44:1552-8.
13. 123I- metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma. J Clin Oncol. 2003;21:2486-91. (Pubitemid 46606329)
14. 123I-Metaiodobenzylguanidine (MIBG) scintigraphy for the staging of neuroblastoma. KAKU IGAKU (Jpn J Nucl Med). 1998; 35:835-42. (Pubitemid 29016876)
15. Hiorns MP, Owens CM. Radiology of neuroblastoma in children. Eur Radiol. 2001;11:2071-81. (Pubitemid 32936913)
16. Papaioannou G, McHugh K. Neuroblastoma in childhood: review and radiological findings. Cancer Imaging. 2005;5:116-27.
17. 123I-mIBG scintigraphy in patients with known or suspected neuroblastoma: results from a prospective multicenter trial. Pediatr Blood Cancer. 2009;52:784-90.
18. Boubaker A, Delaloye AB. Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy. Q J Nucl Med. 2003;47:31-40. (Pubitemid 36826759)
19. Kuchner BH. Neuroblastoma: a disease requiring a multitude of imaging studies. J Nucl Med. 2004;45:1172-88.